Stereokem Pharmaceuticals Private Limited

Stereokem Pharmaceuticals Private Limited - pharma in Visakhapatnam, Andhra Pradesh, India. FY 2026 financials and compliance.
CIN U24100AP2012PTC112863 Incorporated 11 February 2012 ROC Vijayawada HQ Visakhapatnam, Andhra Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2023
₹6.31 Cr
▲ 1010.97% YoY
EBITDA · FY 2023
Locked
In full report
Net profit · FY 2023
Locked
In full report
Authorised capital
₹7 Cr
Registered with MCA
Paid-up capital
₹5 Cr
Issued & subscribed
Open charges
₹13.61 Cr
Secured borrowings
Company age
14 yrs
Est. 2012
Employees · EPFO
48
Latest available

About Stereokem Pharmaceuticals Private Limited

Data last updated: 17 December 2025

Stereokem Pharmaceuticals Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India, a subsidiary of Stereokem Private Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 11 February 2012, the company has been in operation for over 14 years.

Registered with ROC Vijayawada under CIN U24100AP2012PTC112863.

Capital: an authorised share capital of ₹7 Cr and a paid-up capital of ₹5 Cr. Formerly known as Stereo Kem Pharmaceuticals Private Limited. It is led by directors including Thaduri Srivani and Venkateshwar Thaduri Kumar.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Visakhapatnam, Andhra Pradesh.

As per the financials filed for FY 2023, the company reported a revenue of ₹6.31 Cr, reflecting significant growth compared to the previous year.

The company has a workforce of approximately 48 employees as per the latest available data. It operates as a subsidiary of Stereokem Private Limited.

As per MCA filings, the company has open charges of ₹13.61 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stereokem.com.

Company Details of Stereokem Pharmaceuticals Private Limited
CIN U24100AP2012PTC112863
Registration Number 112863
Incorporation Date 11 February 2012
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Stereokem Private Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    Plot No. 27A22 Sy.No.14P Denotified Area – Apsez Iala – Atchutapuram Lalam Koduru (V) Ram, Billi (M), Visakhapatnam, Andhra Pradesh, India – 531061
  • Industry
    Pharma, Drug Formulation & Development
Company report
Stereokem Pharmaceuticals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Stereokem Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Stereokem Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Stereokem Pharmaceuticals Private Limited

Stereokem Pharmaceuticals Private Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100AP2012PTC112863, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24100AP2012PTC112863 Current
U24100TG2012PTC079103 Previous
U24100AP2012PTC079103 Previous

Business Activity of Stereokem Pharmaceuticals Private Limited

Stereokem Pharmaceuticals Private Limited operates primarily in the manufacturing sector. The company has 2 registered business activity segments, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Locked Manufacturing Locked Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Locked Manufacturing Locked Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Detailed business activity records for Stereokem Pharmaceuticals Private Limited

Activity codes and turnover contribution percentages require an active report plan.

  • Activity group codes
  • Detailed activity codes
  • Turnover contribution

Verified entity values are shown only after access is granted.

Auditor Details of Stereokem Pharmaceuticals Private Limited

Stereokem Pharmaceuticals Private Limited is audited by B V SWAMI & CO for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
B V SWAMI & CO Locked Locked Locked
Premium access

Complete auditor history for Stereokem Pharmaceuticals Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Stereokem Pharmaceuticals Private Limited

Stereokem Pharmaceuticals Private Limited is currently managed by 3 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Thaduri Srivani Director 26 Dec 2012 13 Years 6 Months Current
Venkateshwar Thaduri Kumar Director 11 Feb 2012 14 Years 5 Months Current
Narayana Varma Vegiraju Director 31 Mar 2022 4 Years 3 Months Current

Financials of Stereokem Pharmaceuticals Private Limited FY 2024 filings available

Stereokem Pharmaceuticals Private Limited reported revenue of ₹6.31 Cr (up 1010.97% YoY) for FY 2023.

Revenue · FY 2023
₹6.31 Cr ▲ 1010.97%
Premium access

Ten-year financial statements for Stereokem Pharmaceuticals Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Stereokem Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data for Stereokem Pharmaceuticals Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Stereokem Pharmaceuticals Private Limited

Open charges
₹13.61 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Hdfc Bank Limited₹13.61 Cr
Latest charge details
DateLenderAmountStatus
15 Sep 2021 Hdfc Bank Limited ₹11.29 Lakh Open
24 Mar 2021 Hdfc Bank Limited ₹13.5 Cr Open

Total charge records: 2 View all charges

Employees and EPFO Compliance at Stereokem Pharmaceuticals Private Limited

Stereokem Pharmaceuticals Private Limited has a workforce of 48 employees as of Apr 01, 2024.

Employee count
48
Active EPFO establishments
1
Employee growth
26.32%
Premium access

Employee and EPFO history for Stereokem Pharmaceuticals Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Stereokem Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance for Stereokem Pharmaceuticals Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Stereokem Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Stereokem Pharmaceuticals Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Stereokem Pharmaceuticals Private Limited

Premium access

MSME payment history for Stereokem Pharmaceuticals Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Stereokem Pharmaceuticals Private Limited

Premium access

Corporate group structure for Stereokem Pharmaceuticals Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Stereokem Pharmaceuticals Private Limited

Premium access

MCA filings and documents for Stereokem Pharmaceuticals Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Stereokem Pharmaceuticals Private Limited

Activity
30 Sep 2024
Stereokem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Stereokem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.
Charges
21 Jun 2023
A charge with Hdfc Bank Limited of Rs. 13.50 Cr registered on 24 Mar 2021 with Charge ID 100434557 was modified on 21 Jun 2023.
Directors
31 Mar 2022
Narayana Varma Vegiraju was appointed as a Director on 31 Mar 2022 & has been associated with this company since 4 years 3 months.
Charges
15 Sep 2021
A charge with Hdfc Bank Limited amounted to Rs. 0.11 Cr with Charge ID 100500360 was registered on 15 Sep 2021.
Charges
24 Mar 2021
A charge with Hdfc Bank Limited amounted to Rs. 13.50 Cr with Charge ID 100434557 was registered on 24 Mar 2021.

Frequently Asked Questions about Stereokem Pharmaceuticals Private Limited

Stereokem Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in Visakhapatnam, Andhra Pradesh, India. It was incorporated on 11 February 2012 (14+ years old) and is registered under CIN U24100AP2012PTC112863. The company has 48 employees.

Stereokem Pharmaceuticals Private Limited reported revenue of ₹6.31 Cr for FY 2023 (up 1010.97% YoY).

The current directors of Stereokem Pharmaceuticals Private Limited are:

The primary industry of Stereokem Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Stereokem Pharmaceuticals Private Limited can be reached at the registered office: Plot No. 27A22 Sy.No.14P Denotified Area – Apsez Iala – Atchutapuram Lalam Koduru V Ram, Billi M, Visakhapatnam, Andhra Pradesh, India – 531061, or through the website stereokem.com.

The authorised capital is ₹7 Cr, and the paid-up capital is ₹5 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available